The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mulroy Dennis since 2017.
This trader's CIK number is 1276840.
At the time of last reporting, Mulroy Dennis was the CHIEF FINANCIAL OFFICER of Anaptysbio, Inc. (stock ticker symbol ANAB).
Also see all insider trading activities at Anaptysbio, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | LJPC | 500 | $16,975 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ANAB | 0 | $0 | 0 | $0 | 13,538 | $0 |
| 2024 | ANAB | 0 | $0 | 18,965 | $638,606 | 21,245 | $201,600 |
| 2023 | ANAB | 0 | $0 | 6,000 | $116,240 | 6,000 | $0 |
1. La Jolla Pharmaceutical Co (LJPC)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-03 | LJPC | Buy | 500 | 33.95 | 16,975 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-03 | ANAB | Option Ex | 8,293 | .00 | 0 |
| 2025-01-06 | ANAB | Option Ex | 5,245 | .00 | 0 |
| 2024-09-16 | ANAB | Option Ex | 10,000 | 20.16 | 201,600 |
| 2024-09-16 | ANAB | Sale | 12,220 | 39.53 | 483,056 |
| 2024-09-14 | ANAB | Option Ex | 6,000 | .00 | 0 |
| 2024-05-22 | ANAB | Sale | 1,500 | 23.72 | 35,580 |
| 2024-01-30 | ANAB | Sale | 3,065 | 23.63 | 72,425 |
| 2024-01-06 | ANAB | Option Ex | 5,245 | .00 | 0 |
| 2024-01-08 | ANAB | Sale | 2,180 | 21.81 | 47,545 |
| 2023-09-14 | ANAB | Option Ex | 6,000 | .00 | 0 |
| 2023-09-14 | ANAB | Sale | 2,105 | 19.48 | 41,005 |
| 2023-09-18 | ANAB | Sale | 3,895 | 19.32 | 75,235 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mulroy Dennis (CHIEF FINANCIAL OFFICER of Anaptysbio, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.